{"immunity":null,"contraindications":{"vaccineGroup":{"contraindication":[{"observationCode":"080","observationTitle":"Adverse reaction to vaccine component","contraindicationText":"Do not vaccinate if the patient has had an adverse reaction to a vaccine component.","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"099","observationTitle":"Severe allergic reaction after previous dose of Yellow Fever","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Yellow Fever vaccine.","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"101","observationTitle":"Allergic reaction to egg protein","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to egg protein.","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"102","observationTitle":"Severe allergic reaction to gelatin","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to gelatin.","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"105","observationTitle":"Severe allergic reaction to chicken protein","contraindicationText":"Do not vaccinate if the patient has had a severe allergic reaction to chicken protein.","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"145","observationTitle":"B-lymphocyte [humoral] - Severe antibody deficiencies","contraindicationText":"Do not vaccinate if the patient has severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"146","observationTitle":"B-lymphocyte [humoral] - Less severe antibody deficiencies","contraindicationText":"Do not vaccinate if the patient has less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"147","observationTitle":"T-lymphocyte [cell-mediated and humoral] - Complete defects","contraindicationText":"Do not vaccinate if the patient has complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"148","observationTitle":"T-lymphocyte [cell-mediated and humoral] - Partial defects","contraindicationText":"Do not vaccinate if the patient has partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"150","observationTitle":"T-lymphocyte [cell-mediated and humoral] - interferon-gamma or interferon-alpha","contraindicationText":"Do not vaccinate if the patient has cell-mediated or humoral T-lymphocyte defects related to interferon-gamma or interferon-alpha","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"153","observationTitle":"Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency","contraindicationText":"Do not vaccinate if the patient has a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"154","observationTitle":"HIV/AIDS - severely immunocompromised","contraindicationText":"Do not vaccinate if the patient has HIV/AIDS and is severely immunocompromised (See the CDC general recommendations for a definition of \"severely immunocompromised\").","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"156","observationTitle":"Generalized malignant neoplasm","contraindicationText":"Do not vaccinate if the patient has generalized malignant neoplasm.","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"157","observationTitle":"Transplantation","contraindicationText":"Do not vaccinate if the patient received a transplant.","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"158","observationTitle":"Immunosuppressive therapy","contraindicationText":"Do not vaccinate if the patient is undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. ","contraindicationGuidance":null,"beginAge":null,"endAge":null},{"observationCode":"159","observationTitle":"Radiation therapy","contraindicationText":"Do not vaccinate if the patient is undergoing radiation therapy.","contraindicationGuidance":null,"beginAge":null,"endAge":null}]},"vaccine":{"contraindication":[{"observationCode":"009","observationTitle":"Breastfeeding","contraindicationText":"Do not vaccinate if the patient is breastfeeding.","contraindicationGuidance":"Vaccination with Stamaril may occur if the patient is able to suspend breastfeeding for 14 days after administration.","contraindicatedVaccine":[{"vaccineType":"Yellow fever vaccine - alt","cvx":"183","beginAge":"9 months","endAge":null,"tradeName":null,"mvx":null,"volume":null,"forecastVaccineType":null}]}]}},"series":[{"seriesName":"Yellow Fever risk 1-dose series","targetDisease":"Yellow Fever","vaccineGroup":"Yellow Fever","seriesAdminGuidance":null,"seriesType":null,"equivalentSeriesGroups":null,"requiredGender":null,"selectSeries":null,"indication":null,"seriesDose":null}]}